- Home
- AMPH vs CNNE Comparison
AMPH vs CNNE Comparison
Compare AMPH & CNNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPH
- CNNE
- Stock Information
- Founded
- AMPH 1996
- CNNE 2014
- Country
- AMPH United States
- CNNE United States
- Employees
- AMPH N/A
- CNNE N/A
- Industry
- AMPH Biotechnology: Pharmaceutical Preparations
- CNNE Restaurants
- Sector
- AMPH Health Care
- CNNE Consumer Discretionary
- Exchange
- AMPH Nasdaq
- CNNE Nasdaq
- Market Cap
- AMPH 1.1B
- CNNE 1.2B
- IPO Year
- AMPH 2014
- CNNE N/A
- Fundamental
- Price
- AMPH $30.50
- CNNE $18.50
- Analyst Decision
- AMPH Buy
- CNNE Buy
- Analyst Count
- AMPH 5
- CNNE 3
- Target Price
- AMPH $36.20
- CNNE $23.33
- AVG Volume (30 Days)
- AMPH 641.0K
- CNNE 744.0K
- Earning Date
- AMPH 08-07-2025
- CNNE 08-11-2025
- Dividend Yield
- AMPH N/A
- CNNE 3.32%
- EPS Growth
- AMPH N/A
- CNNE N/A
- EPS
- AMPH 2.68
- CNNE N/A
- Revenue
- AMPH $722,679,000.00
- CNNE $437,200,000.00
- Revenue This Year
- AMPH $1.06
- CNNE N/A
- Revenue Next Year
- AMPH $7.06
- CNNE $2.03
- P/E Ratio
- AMPH $11.38
- CNNE N/A
- Revenue Growth
- AMPH 1.37
- CNNE N/A
- 52 Week Low
- AMPH $20.39
- CNNE $15.92
- 52 Week High
- AMPH $53.96
- CNNE $22.36
- Technical
- Relative Strength Index (RSI)
- AMPH 74.11
- CNNE 38.42
- Support Level
- AMPH $29.42
- CNNE $17.69
- Resistance Level
- AMPH $30.99
- CNNE $18.25
- Average True Range (ATR)
- AMPH 1.31
- CNNE 0.60
- MACD
- AMPH 0.51
- CNNE -0.12
- Stochastic Oscillator
- AMPH 93.07
- CNNE 28.97
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
About CNNE Cannae Holdings Inc.
Cannae Holdings Inc is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant Group, Dun & Bradstreet, Alight, BKFC, Corporate and Other. Majority of the company's revenue is generated from its Restaurant Group segment which represents the operations of O'Charley's and Ninety Nine Restaurants.